QPG

Proprietary research · Proprietary capital

AiQuant Research & Trading

AiQuant is QPG's internal research-to-capital workstream. Research develops documented quantamental hypotheses; the trading function evaluates sufficiently developed work through testing, paper trading, risk review, and potential deployment using QPG's own capital.

AiQuant Research

Develop the thesis.

Research is responsible for the question, evidence, assumptions, data, analysis, and documentation that make a hypothesis testable.

  • Healthcare and biotechnology research
  • Company, sector, and thematic analysis
  • Scientific and fundamental research
  • Macroeconomic and geopolitical analysis
  • Research publication and process development

AiQuant Trading

Test before capital.

A research idea does not become a position automatically. The intended pipeline adds progressively stronger evidence and controls before QPG capital is considered.

  1. 01Documented hypothesis and research thesis
  2. 02Structured data and reproducible quantitative testing
  3. 03Backtesting and signal evaluation
  4. 04Paper trading and controlled evaluation
  5. 05Risk review and, when warranted, QPG proprietary-capital deployment

Current priority

Build the process before scaling it.

QPG is strengthening research quality, documentation, reproducibility, testing, review, and risk controls before increasing technical complexity or proprietary capital deployment.

Role inside QPG

Research becomes testable decisions.

The objective is a repeatable internal pipeline in which hypotheses can be challenged, measured, reviewed, and either rejected, refined, or advanced under defined controls.

AiQuant is proprietary and self-funded. QPG does not accept or manage third-party investment capital and does not provide personalized investment advice, portfolio management, brokerage, or asset-management services. Any trading or investment activity is conducted solely for QPG's own account using internal capital.